| http://www.w3.org/ns/prov#value | - 9) which has a binding activity to the cannabinoid type 2 receptor as a nephritis treating agent, (13) the pharmaceutical composition according to any one of (1) to (9) which has a binding activity to the cannabinoid type 2 receptor of any one of (1) to (9) as an analgesic agent, (14) a compound of the formula (I): wherein R1 is a group represented by the formula: ???Y1???Y2???Y3???Ra wherein Y1,
|
